Prospera Financial Services Inc Clovis Oncology, Inc. Transaction History

Prospera Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$0.63 - $2.96 $2,583 - $12,136	4,100 Added 81.19%	9,150 $16,000
Q1 2022 May 04, 2022	BUY	$1.43 - $3.14 $7,221 - $15,857	5,050 New	5,050 $10,000
Q4 2020 Feb 12, 2021	SELL	$4.13 - $6.41 $3,510 - $5,448	-850 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$4.82 - $7.72 $4,097 - $6,562	850 New	850 $5,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.